Colonic endocrine cells in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Cell Biology
• Immunohistochemistry

Background:

• Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), involves complex pathophysiological changes.
• Colonic endocrine cells play crucial roles in regulating gastrointestinal function.
• Alterations in colonic endocrine cell populations may contribute to IBD symptoms.

Purpose of the Study:

• To investigate and quantify specific colonic endocrine cell types in patients diagnosed with UC and CD.
• To compare the distribution and characteristics of these cells between IBD patients and healthy controls.

Main Methods:

• Immunohistochemical staining was employed to identify various colonic endocrine cell types.
• Computed image analysis was utilized for the precise quantification of these identified cell populations.
• Patient cohorts included individuals with UC, CD, and disease-free controls undergoing colon carcinoma surgery.

Main Results:

• Significant increases in argyrophil, chromogranin A, and serotonin-immunoreactive cell areas were noted in both UC and CD patients compared to controls.
• Crohn's disease patients exhibited significantly reduced areas of peptide YY (PYY) and pancreatic polypeptide (PP)-immunoreactive cells, alongside an increased area of enteroglucagon-immunoreactive cells.
• In severe inflammation cases within CD, a decrease in PYY cell area and an increase in enteroglucagon cell area were observed.

Conclusions:

• Elevated serotonin-immunoreactive cell areas in UC and CD may contribute to reduced colonic motility and increased intraluminal pressure.
• Diminished PYY-immunoreactive cell areas in CD patients could be linked to impaired absorption and heightened secretion.
• These findings highlight specific endocrine cell dysregulations in IBD that may underlie key clinical manifestations.